Palliative care infections and antibiotic cost: a vicious circle

References

• Sepúlveda C, Marlin A, Yoshida T, et al. Palliative care: the World Health Organization’s global perspective. J Pain Sympt Manag. 2002;24:91–96.
   PubMed Web of Science ®Google Scholar
• Chochinov HM. Dignity-conserving care – a new model for palliative care: helping the patient feel valued. JAMA. 2002;287:2253–2260.
   PubMed Web of Science ®Google Scholar
• Davies E, Higginson IJ, World health organization. Better palliative care for older people. Copenhagen, Denmark: WHO Regional Office for Europe; 2004.
   Google Scholar
• Vitetta L, Kenner D, Sali A. Bacterial infections in terminally ill hospice patients. J Pain Sympt Manag. 2000;20:326–334.
   PubMed Web of Science ®Google Scholar
• Datta R, Juthani-Mehta M. Burden and management of multidrug-resistant organisms in palliative care. Palliat Care. 2017;10:1178224217749233.
   Google Scholar
• Wakefield DS, Helms CM, Massanari RM, et al. Cost of nosocomial infection: relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections. Am J Infect Control. 1988;16:185–192.
   PubMed Web of Science ®Google Scholar
• Juthani-Mehta M, Malani PN, Mitchell SL. Antimicrobials at the end of life: an opportunity to improve palliative care and infection management. JAMA. 2015;314:2017–2018.
   PubMed Web of Science ®Google Scholar
• Ahronheim JC, Morrison RS, Baskin SA, et al. Treatment of the dying in the acute care hospital. Advanced dementia and metastatic cancer. Arch Intern Med. 1996;156:2094–2100.
   PubMedGoogle Scholar
• Pereira J, Watanabe S, Wolch G. A retrospective review of the frequency of infections and patterns of antibiotic utilization on a palliative care unit. J Pain Symptom Manage. 1998;16:374–381.
   PubMed Web of Science ®Google Scholar
• Schofield P, Carey M, Love A, et al. ‘Would you like to talk about your future treatment options?’Discussing the transition from curative cancer treatment to palliative care. Palliat Med. 2006;20:397–406.
   PubMed Web of Science ®Google Scholar
• Albrecht JS, McGregor JC, Fromme EK, et al. A nationwide analysis of antibiotic use in hospice care in the final week of life. J Pain Symptom Manage. 2013;46:483–490.
   PubMed Web of Science ®Google Scholar
• Dincer M, Kahveci K, Doger C. An examination of factors affecting the length of stay in a palliative care center. J Palliative Med. 2018;21:11–15.
   PubMed Web of Science ®Google Scholar
• Thompson AJ, Silveira MJ, Vitale CA, et al. Antimicrobial use at the end of life among hospitalized patients with advanced cancer. Am J Hosp Palliat Care. 2012;29:599–603.
   PubMed Web of Science ®Google Scholar
• Macedo F, Nunes C, Ladeira K, et al. Antimicrobial therapy in palliative care: an overview. Supportive Care Cancer. 2018;26:1361–1367.
   Web of Science ®Google Scholar
• Nagy-Agren S, Haley HB. Management of infections in palliative care patients with advanced cancer. J Pain Sympt Manag. 2002;24:64–70.
   PubMed Web of Science ®Google Scholar
• Hidron AI, Edwards JR, Patel J, et al. National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29:996–1011.
   PubMed Web of Science ®Google Scholar
• Siegel JD, Rhinehart E, Jackson M, et al. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35:S165–S193.
   PubMed Web of Science ®Google Scholar
• Levin PD, Simor AE, Moses AE, et al. End-of-life treatment and bacterial antibiotic resistance: a potential association. Chest. 2010;138:588–594.
   PubMed Web of Science ®Google Scholar
• Oneschuk D, Fainsinger R, Demoissac D. Antibiotic use in the last week of life in three different palliative care settings. J Palliat Care. 2002;18:25–28.
   Web of Science ®Google Scholar
• Stiel S, Krumm N, Pestinger M, et al. Antibiotics in palliative medicine – results from a prospective epidemiological investigation from the HOPE survey. Support Care Cancer. 2012;20:325–333.
   PubMed Web of Science ®Google Scholar
• Helde-Frankling M, Bergqvist J, Bergman P, et al. Antibiotic treatment in end-of-life cancer patients – a retrospective observational study at a palliative care center in Sweden. Cancers. 2016;8:84.
   Web of Science ®Google Scholar
• White PH, Kuhlenschmidt HL, Vancura BG, et al. Antimicrobial use in patients with advanced cancer receiving hospice care. J Pain Symptom Manage. 2003;25:438–443.
   PubMed Web of Science ®Google Scholar
• Andersen BM. Economic consequences of hospital infections in a 1,000-bed university hospital in Norway. Infect Control Hosp Epidemiol. 1998;19:805–807.
   PubMed Web of Science ®Google Scholar
• Haley RW, Schaberg DR, Von Allmen SD, et al. Estimating the extra charges and prolongation of hospitalization due to nosocomial infections: a comparison of methods. J Infect Dis. 1980;141:248–257.
   PubMed Web of Science ®Google Scholar
• Yalcin A, Hayran M, Ünal S. Economic analysis of nosocomial infections in a Turkish university hospital. J Chemother. 1997;9:411–414.
   PubMed Web of Science ®Google Scholar
• Varol Y, Varol U, Başer Z, et al. The cost of COPD exacerbations managed in hospital. Turk Toraks Dergisi/Turk Thorac J. 2013;14:19–23.
   Google Scholar
• Khandelwal N, Benkeser D, Coe NB, et al. Patterns of cost for patients dying in the intensive care unit and implications for cost savings of palliative care interventions. J Palliative Med. 2016;19:1171–1178.
   PubMed Web of Science ®Google Scholar
• Jarvis WR. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol. 1996;17:552–557.
   PubMed Web of Science ®Google Scholar
• Michel L, McMichan J, Bachy J. Tracheostomy and indwelling central venous line: a hazardous combination? Intensive Care Med. 1979;5:83–86.
   PubMed Web of Science ®Google Scholar
• Chan T, Devaiah AK. Tracheostomy in palliative care. Otolaryngol Clin North Am. 2009;42:133–141.
   PubMed Web of Science ®Google Scholar
• Gotsman M, Whitby J. Respiratory infection following tracheostomy. Thorax. 1964;19:89.
   PubMedGoogle Scholar
• Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462–474.
   PubMed Web of Science ®Google Scholar
• Reinbolt RE, Shenk AM, White PH, et al. Symptomatic treatment of infections in patients with advanced cancer receiving hospice care. J Pain Sympt Manag. 2005;30:175–182.
   PubMed Web of Science ®Google Scholar